benzeneboronic acid has been researched along with Carcinoma, Hepatocellular in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chun, HJ; Hur, W; Kang, BY; Kim, S; Kim, SM; Kim, WJ; Lee, J; Tak, E; Yoon, SK | 1 |
1 other study(ies) available for benzeneboronic acid and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Phenylboronic acid conjugated to doxorubicin nanocomplexes as an anti-cancer drug delivery system in hepatocellular carcinoma.
Topics: Animals; Antibiotics, Antineoplastic; Boronic Acids; Carcinoma, Hepatocellular; Cell Line, Tumor; Doxorubicin; Drug Delivery Systems; Humans; Liver Neoplasms; Male; Mice; Mice, Inbred C57BL; Nanoconjugates; Xenograft Model Antitumor Assays | 2021 |